This study is for people with high cholesterol, which means they have too much fat in their blood. We are looking at a medicine called enlicitide decanoate. This is an oral PCSK9 inhibitor, a type of medicine that helps lower cholesterol by blocking a protein called PCSK9. To join this study, you must have finished a previous study with enlicitide decanoate. You should have also followed the study rules well and not stopped the medicine early.

If you had a bad reaction in the last study, you won't be able to join. Also, you can't join if you plan to start a different cholesterol medicine or if you're in another clinical study right now.

• Participants must have completed a related study before joining.
• You must have followed the previous study rules well.
• You can't join if you had serious side effects in the last study.